{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:43:48Z","timestamp":1791585828277,"version":"4.3.4"},"reference-count":180,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002954","name":"University of Milano-Bicocca","doi-asserted-by":"publisher","award":["2020-ATE-0024"],"award-info":[{"award-number":["2020-ATE-0024"]}],"id":[{"id":"10.13039\/501100002954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Facioscapulohumeral muscular dystrophy (FSHD) represents the third most common form of muscular dystrophy and is characterized by muscle weakness and atrophy. FSHD is caused by the altered expression of the transcription factor double homeobox 4 (DUX4), which is involved in several significantly altered pathways required for myogenesis and muscle regeneration. While DUX4 is normally silenced in the majority of somatic tissues in healthy individuals, its epigenetic de-repression has been linked to FSHD, resulting in DUX4 aberrant expression and cytotoxicity in skeletal muscle cells. Understanding how DUX4 is regulated and functions could provide useful information not only to further understand FSHD pathogenesis, but also to develop therapeutic approaches for this disorder. Therefore, this review discusses the role of DUX4 in FSHD by examining the possible molecular mechanisms underlying the disease as well as novel pharmacological strategies targeting DUX4 aberrant expression.<\/jats:p>","DOI":"10.3390\/ijms24119503","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T04:40:51Z","timestamp":1685508051000},"page":"9503","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-3676","authenticated-orcid":false,"given":"Elisa","family":"Duranti","sequence":"first","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-5974","authenticated-orcid":false,"given":"Chiara","family":"Villa","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1180","DOI":"10.1212\/WNL.0000000000008123","article-title":"Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD)","volume":"93","author":"Hamel","year":"2019","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Caputo, V., Megalizzi, D., Fabrizio, C., Termine, A., Colantoni, L., Caltagirone, C., Giardina, E., Cascella, R., and Strafella, C. (2022). Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD. Cells, 11.","DOI":"10.3390\/cells11172687"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Himeda, C.L., and Jones, P.L. (2022). FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?. J. Pers. Med., 12.","DOI":"10.3390\/jpm12060865"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11910-016-0667-0","article-title":"Facioscapulohumeral Dystrophy","volume":"16","author":"Wang","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.0.CO;2-R","article-title":"The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females","volume":"77","author":"Zatz","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1086\/302730","article-title":"De novo facioscapulohumeral muscular dystrophy: Frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10","volume":"66","author":"Deidda","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Chen, T.H., Wu, Y.Z., and Tseng, Y.H. (2020). Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207783"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.0000000000001783","article-title":"Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine","volume":"85","author":"Tawil","year":"2015","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1212\/WNL.44.3_Part_1.442","article-title":"Facioscapulohumeral muscular dystrophy (FSHD): Design of natural history study and results of baseline testing. FSH-DY Group","volume":"44","author":"Tawil","year":"1994","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2044-5040-4-12","article-title":"Facioscapulohumeral dystrophy: The path to consensus on pathophysiology","volume":"4","author":"Tawil","year":"2014","journal-title":"Skelet. Muscle"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbadis.2014.05.021","article-title":"Facioscapulohumeral muscular dystrophy","volume":"1852","author":"Sacconi","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zernov, N., and Skoblov, M. (2019). Genotype-phenotype correlations in FSHD. BMC Med. Genom., 12.","DOI":"10.1186\/s12920-019-0488-5"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Snider, L., Geng, L.N., Lemmers, R.J., Kyba, M., Ware, C.B., Nelson, A.M., Tawil, R., Filippova, G.N., van der Maarel, S.M., and Tapscott, S.J. (2010). Facioscapulohumeral dystrophy: Incomplete suppression of a retrotransposed gene. PLoS Genet., 6.","DOI":"10.1371\/journal.pgen.1001181"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Das, S., and Chadwick, B.P. (2016). Influence of Repressive Histone and DNA Methylation upon D4Z4 Transcription in Non-Myogenic Cells. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160022"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s13311-018-00675-3","article-title":"Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments","volume":"15","author":"Hamel","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2012.01647.x","article-title":"DUX4 expression in FSHD muscle cells: How could such a rare protein cause a myopathy?","volume":"17","author":"Tassin","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jb\/mvy019","article-title":"The roles of muscle stem cells in muscle injury, atrophy and hypertrophy","volume":"163","author":"Fukada","year":"2018","journal-title":"J. Biochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e1462","DOI":"10.1002\/wsbm.1462","article-title":"Skeletal muscle: A review of molecular structure and function, in health and disease","volume":"12","author":"Mukund","year":"2020","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/cphy.c100092","article-title":"Mechanisms of muscle injury, repair, and regeneration","volume":"1","author":"Tidball","year":"2011","journal-title":"Compr. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.nmd.2018.06.009","article-title":"Personalized gene and cell therapy for Duchenne Muscular Dystrophy","volume":"28","author":"Wein","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"dmm042192","DOI":"10.1242\/dmm.042192","article-title":"Skeletal muscle in health and disease","volume":"13","author":"Morgan","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1242\/dev.114223","article-title":"Intrinsic and extrinsic mechanisms regulating satellite cell function","volume":"142","author":"Dumont","year":"2015","journal-title":"Development"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1242\/dev.067595","article-title":"An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration","volume":"138","author":"Lepper","year":"2011","journal-title":"Development"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.stemcr.2018.01.027","article-title":"Loss of MyoD and Myf5 in Skeletal Muscle Stem Cells Results in Altered Myogenic Programming and Failed Regeneration","volume":"10","author":"Yamamoto","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ceb.2009.10.002","article-title":"Muscle stem cells","volume":"21","author":"Relaix","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1242\/dev.068858","article-title":"Effective fiber hypertrophy in satellite cell-depleted skeletal muscle","volume":"138","author":"McCarthy","year":"2011","journal-title":"Development"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcdb.2017.11.010","article-title":"The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration","volume":"72","author":"Brun","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Shirakawa, T., Toyono, T., Inoue, A., Matsubara, T., Kawamoto, T., and Kokabu, S. (2022). Factors Regulating or Regulated by Myogenic Regulatory Factors in Skeletal Muscle Stem Cells. Cells, 11.","DOI":"10.3390\/cells11091493"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"a008342","DOI":"10.1101\/cshperspect.a008342","article-title":"Building muscle: Molecular regulation of myogenesis","volume":"4","author":"Bentzinger","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10974-015-9436-y","article-title":"From pluripotency to myogenesis: A multistep process in the dish","volume":"36","author":"Ciemerych","year":"2015","journal-title":"J. Muscle Res. Cell. Motil."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hauerslev, S., Vissing, J., and Krag, T.O. (2014). Muscle atrophy reversed by growth factor activation of satellite cells in a mouse muscle atrophy model. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100594"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Koganti, P., Yao, J., and Cleveland, B.M. (2020). Molecular Mechanisms Regulating Muscle Plasticity in Fish. Animals, 11.","DOI":"10.3390\/ani11010061"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kaczmarek, A., Kaczmarek, M., Cia\u0142owicz, M., Clemente, F.M., Wola\u0144ski, P., Badicu, G., and Murawska-Cia\u0142owicz, E. (2021). The Role of Satellite Cells in Skeletal Muscle Regeneration-The Effect of Exercise and Age. Biology, 10.","DOI":"10.3390\/biology10101056"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1134\/S106235902005009X","article-title":"The Myogenic Potential of Mesenchymal Stromal Cells and Their Effect on Skeletal Muscle Regeneration","volume":"47","author":"Sheveleva","year":"2020","journal-title":"Biol. Bull. Russ. Acad. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fochi, S., Giuriato, G., De Simone, T., Gomez-Lira, M., Tamburin, S., Del Piccolo, L., Schena, F., Venturelli, M., and Romanelli, M.G. (2020). Regulation of microRNAs in Satellite Cell Renewal, Muscle Function, Sarcopenia and the Role of Exercise. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186732"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Forcina, L., Cosentino, M., and Musar\u00f2, A. (2020). Mechanisms Regulating Muscle Regeneration: Insights into the Interrelated and Time-Dependent Phases of Tissue Healing. Cells, 9.","DOI":"10.3390\/cells9051297"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1242\/dev.151035","article-title":"Making muscle: Skeletal myogenesis in vivo and in vitro","volume":"144","author":"Chal","year":"2017","journal-title":"Development"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00418-012-0972-x","article-title":"Myogenesis and muscle regeneration","volume":"138","author":"Yusuf","year":"2012","journal-title":"Histochem. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13507","DOI":"10.1073\/pnas.0405361101","article-title":"Hematopoietic contribution to skeletal muscle regeneration by myelomonocytic precursors","volume":"101","author":"Doyonnas","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.it.2005.08.002","article-title":"IGF-1, inflammation and stem cells: Interactions during muscle regeneration","volume":"26","author":"Mourkioti","year":"2005","journal-title":"Trends Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00043.2011","article-title":"Satellite cells and the muscle stem cell niche","volume":"93","author":"Yin","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Romagnoli, C., Iantomasi, T., and Brandi, M.L. (2021). Available In Vitro Models for Human Satellite Cells from Skeletal Muscle. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413221"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semcdb.2020.02.004","article-title":"Mechanisms regulating myoblast fusion: A multilevel interplay","volume":"104","author":"Lehka","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"113134","DOI":"10.1016\/j.yexcr.2022.113134","article-title":"Regulation of the myoblast fusion reaction for muscle development, regeneration, and adaptations","volume":"415","author":"Millay","year":"2022","journal-title":"Exp. Cell Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.bbamem.2014.08.023","article-title":"Complementary biophysical tools to investigate lipid specificity in the interaction between bioactive molecules and the plasma membrane: A review","volume":"1838","author":"Deleu","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/j.yexcr.2009.07.010","article-title":"Dynamic clustering and dispersion of lipid rafts contribute to fusion competence of myogenic cells","volume":"315","author":"Mukai","year":"2009","journal-title":"Exp. Cell Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1534-5807(03)00118-7","article-title":"Beta1 integrins regulate myoblast fusion and sarcomere assembly","volume":"4","author":"Schwander","year":"2003","journal-title":"Dev. Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.ctm.2015.10.006","article-title":"Plasma Membrane Repair in Health and Disease","volume":"77","author":"Demonbreun","year":"2016","journal-title":"Curr. Top. Membr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/WCO.0b013e328357f22d","article-title":"Facioscapulohumeral muscular dystrophy: Consequences of chromatin relaxation","volume":"25","author":"Miller","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1212\/WNL.0000000000000708","article-title":"Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers","volume":"83","author":"Gaillard","year":"2014","journal-title":"Neurology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"18157","DOI":"10.1073\/pnas.0708659104","article-title":"DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1","volume":"104","author":"Dixit","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.expneurol.2008.07.022","article-title":"DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation","volume":"214","author":"Bosnakovski","year":"2008","journal-title":"Exp. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2011.01.001","article-title":"Facioscapulohumeral muscular dystrophy and DUX4: Breaking the silence","volume":"17","author":"Tawil","year":"2011","journal-title":"Trends Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ng1262","article-title":"Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy","volume":"35","author":"Lemmers","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/cge.13726","article-title":"Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy","volume":"97","author":"Greco","year":"2020","journal-title":"Clin. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00412-006-0080-6","article-title":"Hybridization analysis of D4Z4 repeat arrays linked to FSHD","volume":"116","author":"Ehrlich","year":"2007","journal-title":"Chromosoma"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0092-8674(02)00826-7","article-title":"Inappropriate gene activation in FSHD: A repressor complex binds a chromosomal repeat deleted in dystrophic muscle","volume":"110","author":"Gabellini","year":"2002","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/jmg.2004.019364","article-title":"FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients","volume":"41","author":"Rijkers","year":"2004","journal-title":"J. Med. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20522","article-title":"Facioscapulohumeral muscular dystrophy","volume":"34","author":"Tawil","year":"2006","journal-title":"Muscle Nerve"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mrfmmm.2008.07.011","article-title":"Epigenetic mechanisms of facioscapulohumeral muscular dystrophy","volume":"647","author":"Frants","year":"2008","journal-title":"Mutat. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/01.WNL.0000078889.51444.81","article-title":"D4F104S1 deletion in facioscapulohumeral muscular dystrophy: Phenotype, size, and detection","volume":"61","author":"Lemmers","year":"2003","journal-title":"Neurology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/ejhg.2009.62","article-title":"Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level","volume":"17","author":"Klooster","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"102450","DOI":"10.1016\/j.redox.2022.102450","article-title":"ANT1 overexpression models: Some similarities with facioscapulohumeral muscular dystrophy","volume":"56","author":"Arbogast","year":"2022","journal-title":"Redox Biol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Caruso, N., Herberth, B., Bartoli, M., Puppo, F., Dumonceaux, J., Zimmermann, A., Denadai, S., Leboss\u00e9, M., Roche, S., and Geng, L. (2013). Deregulation of the protocadherin gene FAT1 alters muscle shapes: Implications for the pathogenesis of facioscapulohumeral dystrophy. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003550"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ana.24446","article-title":"Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy","volume":"78","author":"Mariot","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3349\/ymj.2018.59.2.337","article-title":"FAT1 Gene Alteration in Facioscapulohumeral Muscular Dystrophy Type 1","volume":"59","author":"Park","year":"2018","journal-title":"Yonsei Med. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1242\/dev.077461","article-title":"Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity","volume":"139","author":"Saburi","year":"2012","journal-title":"Development"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.nmd.2021.09.010","article-title":"Facioscapulohumeral muscular dystrophy type 2: An update on the clinical, genetic, and molecular findings","volume":"31","author":"Jia","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"ref_69","first-page":"401","article-title":"Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD)","volume":"53","author":"Gilbert","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/dmcn.14142","article-title":"Clinical features of facioscapulohumeral muscular dystrophy 1 in childhood","volume":"61","author":"Steel","year":"2019","journal-title":"Dev. Med. Child. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2013.08.004","article-title":"The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1","volume":"93","author":"Sacconi","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/ejhg.2014.191","article-title":"Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1","volume":"23","author":"Larsen","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e2273","DOI":"10.1212\/WNL.0000000000007456","article-title":"FSHD1 and FSHD2 form a disease continuum","volume":"92","author":"Sacconi","year":"2019","journal-title":"Neurology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","article-title":"Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy","volume":"98","author":"Lemmers","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"14412","DOI":"10.1073\/pnas.96.25.14412","article-title":"The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome","volume":"96","author":"Hansen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/jmedgenet-2020-107041","article-title":"Chromosome 10q-linked FSHD identifies DUX4 as principal disease gene","volume":"59","author":"Lemmers","year":"2022","journal-title":"J. Med. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/hmg\/5.12.1997","article-title":"Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: Implications for genetic counselling and etiology of FSHD1","volume":"5","author":"Bakker","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jmedgenet-2018-105949","article-title":"Deciphering the complexity of the 4q and 10q subtelomeres by molecular combing in healthy individuals and patients with facioscapulohumeral dystrophy","volume":"56","author":"Nguyen","year":"2019","journal-title":"J. Med. Genet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/jmedgenet-2019-106402","article-title":"Intronic SMCHD1 variants in FSHD: Testing the potential for CRISPR-Cas9 genome editing","volume":"56","author":"Goossens","year":"2019","journal-title":"J. Med. Genet."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/hmg\/ddab250","article-title":"High-resolution breakpoint junction mapping of proximally extended D4Z4 deletions in FSHD1 reveals evidence for a founder effect","volume":"31","author":"Lemmers","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1093\/hmg\/ddy236","article-title":"Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2","volume":"27","author":"Lemmers","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ejhg.2015.55","article-title":"Double SMCHD1 variants in FSHD2: The synergistic effect of two SMCHD1 variants on D4Z4 hypomethylation and disease penetrance in FSHD2","volume":"24","author":"Lemmers","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gde.2015.08.007","article-title":"Genetic and epigenetic contributors to FSHD","volume":"33","author":"Daxinger","year":"2015","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Corona, E.D., Jacquelin, D., Gatica, L., and Rosa, A.L. (2013). Multiple protein domains contribute to nuclear import and cell toxicity of DUX4, a candidate pathogenic protein for facioscapulohumeral muscular dystrophy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075614"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1096\/fj.201902696","article-title":"DNA aptamers against the DUX4 protein reveal novel therapeutic implications for FSHD","volume":"34","author":"Klingler","year":"2020","journal-title":"FASEB J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bbrc.2018.10.056","article-title":"Structural basis for multiple gene regulation by human DUX4","volume":"505","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.celrep.2018.11.060","article-title":"Crystal Structure of the Double Homeodomain of DUX4 in Complex with DNA","volume":"25","author":"Lee","year":"2018","journal-title":"Cell Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ng.3844","article-title":"Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL\/HERVL retrotransposons","volume":"49","author":"Hendrickson","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ng.3858","article-title":"DUX-family transcription factors regulate zygotic genome activation in placental mammals","volume":"49","author":"Planet","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/ng.3846","article-title":"Conservation and innovation in the DUX4-family gene network","volume":"49","author":"Whiddon","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"104137","DOI":"10.1016\/j.isci.2022.104137","article-title":"DUX4 is a multifunctional factor priming human embryonic genome activation","volume":"25","author":"Vuoristo","year":"2022","journal-title":"iScience"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41422-019-0238-4","article-title":"Precise temporal regulation of Dux is important for embryo development","volume":"29","author":"Guo","year":"2019","journal-title":"Cell Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1098\/rstb.2009.0124","article-title":"Male germ cell apoptosis: Regulation and biology","volume":"365","author":"Shaha","year":"2010","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1084\/jem.20181444","article-title":"The transcription factor Duxbl mediates elimination of pre-T cells that fail \u03b2-selection","volume":"216","author":"Klein","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","article-title":"DUX4 activates germline genes, retroelements, and immune mediators: Implications for facioscapulohumeral dystrophy","volume":"22","author":"Geng","year":"2012","journal-title":"Dev. Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1093\/hmg\/ddv315","article-title":"Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways","volume":"24","author":"Rickard","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/humu.24171","article-title":"Relationship of DUX4 and target gene expression in FSHD myocytes","volume":"42","author":"Chau","year":"2021","journal-title":"Hum. Mutat."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/hmg\/ddz242","article-title":"DUX4-induced bidirectional HSATII satellite repeat transcripts form intranuclear double-stranded RNA foci in human cell models of FSHD","volume":"28","author":"Shadle","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Young, J.M., Whiddon, J.L., Yao, Z., Kasinathan, B., Snider, L., Geng, L.N., Balog, J., Tawil, R., van der Maarel, S.M., and Tapscott, S.J. (2013). DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003947"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4172\/2157-7412.1000303","article-title":"PARP1 Differentially Interacts with Promoter region of DUX4 Gene in FSHD Myoblasts","volume":"7","author":"Sharma","year":"2016","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13395-017-0134-x","article-title":"BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells","volume":"7","author":"Campbell","year":"2017","journal-title":"Skelet. Muscle"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1074\/jbc.RA118.002633","article-title":"Protein kinase A activation inhibits DUX4 gene expression in myotubes from patients with facioscapulohumeral muscular dystrophy","volume":"293","author":"Cruz","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/jpet.119.259663","article-title":"Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy","volume":"370","author":"Oliva","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41564-018-0285-5","article-title":"Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrity","volume":"4","author":"Full","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3535","article-title":"Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults","volume":"48","author":"Yasuda","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_107","first-page":"236","article-title":"Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: Expanding the clinical spectrum","volume":"52","author":"Brodowicz","year":"2020","journal-title":"Pathology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13023-021-01760-1","article-title":"Facioscapulohumeral muscular dystrophy: Genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: An update","volume":"16","author":"Kaiser","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.freeradbiomed.2016.08.007","article-title":"DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients","volume":"99","author":"Dmitriev","year":"2016","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1038\/s41598-018-35150-8","article-title":"Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression","volume":"8","author":"Bosnakovski","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1582-4934.2008.00368.x","article-title":"Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects","volume":"14","author":"Barro","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2014.02.105","article-title":"Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression","volume":"446","author":"Xu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Esteves de Lima, J., and Relaix, F. (2021). Epigenetic Regulation of Myogenesis: Focus on the Histone Variants. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312727"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13072-015-0027-3","article-title":"Tissue-specific expression of histone H3 variants diversified after species separation","volume":"8","author":"Maehara","year":"2015","journal-title":"Epigenetics Chromatin"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.celrep.2019.10.025","article-title":"DUX4-Induced Histone Variants H3.X and H3.Y Mark DUX4 Target Genes for Expression","volume":"29","author":"Resnick","year":"2019","journal-title":"Cell Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"eaaw7781","DOI":"10.1126\/sciadv.aaw7781","article-title":"A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death","volume":"5","author":"Bosnakovski","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.devcel.2019.06.011","article-title":"DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade","volume":"50","author":"Chew","year":"2019","journal-title":"Dev. Cell"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Walter, S., Franke, V., Drayman, N., Wyler, E., Tay, S., Landthaler, M., Akalin, A., Ensser, A., and Full, F. (2021). Herpesviral induction of germline transcription factor DUX4 is critical for viral gene expression. bioRxiv.","DOI":"10.1101\/2021.03.24.436599"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Tassin, A., Vanderplanck, C., Sauvage, S., Barro, M., Mahieu, I., Leroy, A., and Leclercq, I. (2009). DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007482"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"34989","DOI":"10.1074\/jbc.M113.504522","article-title":"Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients","volume":"288","author":"Dmitriev","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Ansseau, E., Vanderplanck, C., Wauters, A., Harper, S.Q., Copp\u00e9e, F., and Belayew, A. (2017). Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes, 8.","DOI":"10.3390\/genes8030093"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Ansseau, E., Eidahl, J.O., Lancelot, C., Tassin, A., Matteotti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., and Gerbaux, C. (2016). Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146893"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13395-022-00310-y","article-title":"The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins","volume":"13","author":"Claus","year":"2023","journal-title":"Skelet. Muscle"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1093\/hmg\/ddy162","article-title":"Facioscapulohumeral dystrophy: Activating an early embryonic transcriptional program in human skeletal muscle","volume":"27","author":"Campbell","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Shadle, S.C., Zhong, J.W., Campbell, A.E., Conerly, M.L., Jagannathan, S., Wong, C.J., Morello, T.D., van der Maarel, S.M., and Tapscott, S.J. (2017). DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy. PLoS Genet., 13.","DOI":"10.1371\/journal.pgen.1006658"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/hmg\/ddt409","article-title":"DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles","volume":"23","author":"Ferreboeuf","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Jones, T., and Jones, P.L. (2018). A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192657"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1242\/jcs.205427","article-title":"The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain","volume":"130","author":"Bosnakovski","year":"2017","journal-title":"J. Cell Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/mus.24621","article-title":"Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies","volume":"52","author":"Statland","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Janssen, B.H., Voet, N.B., Nabuurs, C.I., Kan, H.E., de Rooy, J.W., Geurts, A.C., Padberg, G.W., van Engelen, B.G., and Heerschap, A. (2014). Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085416"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1242\/jcs.180372","article-title":"DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis","volume":"129","author":"Knopp","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1093\/hmg\/dds284","article-title":"Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: Evidence for disease modifiers and a quantitative model of pathogenesis","volume":"21","author":"Jones","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Sharma, V., Harafuji, N., Belayew, A., and Chen, Y.W. (2013). DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064691"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e13695","DOI":"10.15252\/emmm.202013695","article-title":"Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: Roles of DUX4 and PAX7","volume":"13","author":"Banerji","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Lim, K.R.Q., Nguyen, Q., and Yokota, T. (2020). DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030729"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/hmg\/ddz043","article-title":"PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level","volume":"28","author":"Banerji","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13395-017-0130-1","article-title":"Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures","volume":"7","author":"Haynes","year":"2017","journal-title":"Skelet. Muscle"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/15592294.2015.1113798","article-title":"Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4","volume":"10","author":"Balog","year":"2015","journal-title":"Epigenetics"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1002\/pmic.200600056","article-title":"Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes","volume":"6","author":"Celegato","year":"2006","journal-title":"Proteomics"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Tsumagari, K., Chang, S.C., Lacey, M., Baribault, C., Chittur, S.V., Sowden, J., Tawil, R., Crawford, G.E., and Ehrlich, M. (2011). Gene expression during normal and FSHD myogenesis. BMC Med. Genom., 4.","DOI":"10.1186\/1755-8794-4-67"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00441-014-2016-4","article-title":"Desmin in muscle and associated diseases: Beyond the structural function","volume":"360","author":"Hnia","year":"2015","journal-title":"Cell Tissue Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13395-017-0148-4","article-title":"Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei","volume":"8","author":"Vanderplanck","year":"2018","journal-title":"Skelet. Muscle"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.apmr.2008.12.027","article-title":"Periodic salbutamol in facioscapulohumeral muscular dystrophy: A randomized controlled trial","volume":"90","author":"Payan","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.omtn.2021.09.010","article-title":"Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy","volume":"26","author":"Bouwman","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1038\/s41467-021-27430-1","article-title":"Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy","volume":"12","author":"Saad","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.omtn.2021.05.020","article-title":"Adenine base editing of the DUX4 polyadenylation signal for targeted genetic therapy in facioscapulohumeral muscular dystrophy","volume":"25","author":"Cadar","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/hmg\/ddw015","article-title":"Antisense targeting of 3\u2032 end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: A new gene-silencing approach","volume":"25","author":"Marsollier","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Sardone, V., Zhou, H., Muntoni, F., Ferlini, A., and Falzarano, M.S. (2017). Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease. Molecules, 22.","DOI":"10.3390\/molecules22040563"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/hmg\/ddab136","article-title":"Systemic antisense therapeutics inhibiting DUX4 expression ameliorates FSHD-like pathology in an FSHD mouse model","volume":"30","author":"Malerba","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"16509","DOI":"10.1073\/pnas.1909649117","article-title":"Inhibition of DUX4 expression with antisense LNA gapmers as a therapy for facioscapulohumeral muscular dystrophy","volume":"117","author":"Lim","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1038\/s41598-017-03850-2","article-title":"LNA\/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts","volume":"7","author":"Touznik","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Bittel, A.J., Sreetama, S.C., Bittel, D.C., Horn, A., Novak, J.S., Yokota, T., Zhang, A., Maruyama, R., Rowel, Q.L.K., and Jaiswal, J.K. (2020). Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155575"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA Versus miRNA as Therapeutics for Gene Silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Sidlauskaite, E., Le Gall, L., Mariot, V., and Dumonceaux, J. (2020). DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation. J. Pers. Med., 10.","DOI":"10.3390\/jpm10030073"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Condrat, C.E., Thompson, D.C., Barbu, M.G., Bugnar, O.L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S.M., and Voinea, S.C. (2020). miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells, 9.","DOI":"10.3390\/cells9020276"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-2011-110074","article-title":"Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer\u2019s disease: Genetics and expression analysis","volume":"26","author":"Serpente","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.omtm.2017.12.005","article-title":"Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD","volume":"8","author":"Wallace","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.3748\/wjg.v19.i20.2985","article-title":"Role of microRNAs in the immune system, inflammation and cancer","volume":"19","author":"Raisch","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1124\/jpet.119.264689","article-title":"p38\u03b1 Regulates Expression of DUX4 in a Model of Facioscapulohumeral Muscular Dystrophy","volume":"374","author":"Rojas","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fcell.2014.00021","article-title":"Regulation of myogenic activation of p38 MAPK by TACE-mediated TNF\u03b1 release","volume":"2","author":"Li","year":"2014","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_162","first-page":"91","article-title":"Regulation of Muscle Stem Cell Functions: A Focus on the p38 MAPK Signaling Pathway","volume":"4","author":"Perdiguero","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1111\/bcp.14884","article-title":"Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement","volume":"87","author":"Mellion","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e877","DOI":"10.1212\/WNL.0000000000200757","article-title":"Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional Analysis","volume":"99","author":"Mellion","year":"2022","journal-title":"Neurology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2044-5040-4-4","article-title":"High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity","volume":"4","author":"Bosnakovski","year":"2014","journal-title":"Skelet. Muscle"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2014.09.014","article-title":"Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: A double-blind randomized controlled clinical trial","volume":"81","author":"Passerieux","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MRR.0000000000000444","article-title":"Rasch analysis to evaluate the motor function measure for patients with facioscapulohumeral muscular dystrophy","volume":"44","author":"Mul","year":"2021","journal-title":"Int. J. Rehabil. Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/mus.26088","article-title":"Facioscapulohumeral muscular dystrophy functional composite outcome measure","volume":"58","author":"Eichinger","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nmd.2019.05.006","article-title":"Longitudinal study of upper extremity reachable workspace in fascioscapulohumeral muscular dystrophy","volume":"29","author":"Hatch","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.molmed.2021.03.008","article-title":"Control of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Cancer","volume":"27","author":"Karpukhina","year":"2021","journal-title":"Trends Mol. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1021\/acs.jmedchem.8b01943","article-title":"Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib","volume":"62","author":"Lee","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.drudis.2010.01.008","article-title":"Building on bortezomib: Second-generation proteasome inhibitors as anti-cancer therapy","volume":"15","author":"Dick","year":"2010","journal-title":"Drug Discov. Today"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Alam, K., Farasyn, T., Crowe, A., Ding, K., and Yue, W. (2017). Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186924"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/acn3.158","article-title":"Expression of FSHD-related DUX4-FL alters proteostasis and induces TDP-43 aggregation","volume":"2","author":"Homma","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Bachiller, S., Alonso-Bellido, I.M., Real, L.M., P\u00e9rez-Villegas, E.M., Venero, J.L., Deierborg, T., Armengol, J., and Ruiz, R. (2020). The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176429"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41598-019-55752-0","article-title":"Author Correction: Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs","volume":"10","author":"Nakai","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.ymthe.2018.04.019","article-title":"Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy","volume":"26","author":"Himeda","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/mt.2016.111","article-title":"Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics","volume":"24","author":"Chen","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/mt.2012.68","article-title":"RNA interference inhibits DUX4-induced muscle toxicity in vivo: Implications for a targeted FSHD therapy","volume":"20","author":"Wallace","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13395-022-00287-8","article-title":"Meeting report: The 2021 FSHD International Research Congress","volume":"12","author":"Jagannathan","year":"2022","journal-title":"Skelet. Muscle"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9503\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:45:23Z","timestamp":1760125523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":180,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms24119503"],"URL":"https:\/\/doi.org\/10.3390\/ijms24119503","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]}}}